Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. - Wikidata - wikimedia - TriplyDB

Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells.

Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells.

http://www.wikidata.org/entity/Q51003792

about

The Effect of Biomaterials Used for Tissue Regeneration Purposes on Polarization of Macrophages Innate Immunity and Biomaterials at the Nexus: Friends or Foes Biocompatible materials for continuous glucose monitoring devices Tissue engineering tools for modulation of the immune response Effect of Blood Component Coatings of Enosseal Implants on Proliferation and Synthetic Activity of Human Osteoblasts and Cytokine Production of Peripheral Blood Mononuclear Cells Instability of self-assembled monolayers as a model material system for macrophage/FBGC cellular behavior.Utilizing the Foreign Body Response to Grow Tissue Engineered Blood Vessels in Vivo.Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries The functional behavior of a macrophage/fibroblast co-culture model derived from normal and diabetic mice with a marine gelatin-oxidized alginate hydrogel Induction of angiogenesis and neovascularization in adjacent tissue of plasma-collagen-coated silicone implants Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine.Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro.Giant cell formation and function.Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties.Extended culture of macrophages from different sources and maturation results in a common M2 phenotype.Controlled release strategies for modulating immune responses to promote tissue regeneration Correlating macrophage morphology and cytokine production resulting from biomaterial contact.Phenotypic dichotomies in the foreign body reaction.Foreign body reaction to biomaterials.Macrophage differentiation and polarization on a decellularized pericardial biomaterial Materials that harness and modulate the immune system.Elucidation of adhesion-dependent spontaneous apoptosis in macrophages using phase separated PEG/polyurethane films.The significance of macrophage phenotype in cancer and biomaterials.Localized immunosuppressive environment in the foreign body response to implanted biomaterials.Paracrine and juxtacrine lymphocyte enhancement of adherent macrophage and foreign body giant cell activation.Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites.Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production.A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis Integrin-directed modulation of macrophage responses to biomaterials.Biocompatibility of implants: lymphocyte/macrophage interactions.Mesh biocompatibility: effects of cellular inflammation and tissue remodelling.Challenges and future prospects for tissue engineering in female pelvic medicine and reconstructive surgery.Manipulating the intersection of angiogenesis and inflammation Novel grooved substrata stimulate macrophage fusion, CCL2 and MMP-9 secretion.Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction.Impact of surface chemistry and topography on the function of antigen presenting cells.Biomimetic collagenous scaffold to tune inflammation by targeting macrophages.Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus.Antibacterial activity and cytocompatibility of an implant coating consisting of TiO2 nanotubes combined with a GL13K antimicrobial peptide.

P2860

Q26767055-823767D3-4156-423F-9AC1-F486EFC2441B Q26801604-705C119C-439F-48C0-A73D-CDA8B8CFF147 Q26823654-EEB86B62-D8FC-4F68-A8EF-2A6A93847110 Q27023419-0E56D48E-AEE0-4922-B14A-3D4EE414E2CF Q27349173-41BEB7F8-D2DD-40E4-9A60-CE0D51807840 Q33597281-2D962DB4-D719-4ED7-B948-5A153EAB945A Q33705095-921DBDEC-5539-4D44-A7F6-FE2C56691041 Q33804138-ADD32174-B4FD-45B6-8581-04F50A26BD25 Q33875878-E17522A3-4EED-4C16-8471-0B9C426C91D2 Q34167884-0E7F3973-B166-4C94-BF5E-91B6E0F7DBE1 Q34385682-B1EDA8B6-1513-4101-AD1F-D9B9A6572D20 Q34534814-E589AB4E-BFC4-43E8-81CD-2AA180F65AA9 Q34895680-15AB2019-C2E0-4A39-9AEF-A13A42BD9A92 Q34958651-C940B531-2128-43C7-8539-13354DC640F7 Q34978459-D49EF2AC-0A88-42DA-8C1B-126E8F1E8185 Q35904647-9BFF67E4-DD58-46AC-ACCF-1F7DEE5467C5 Q36307642-E0F85914-9282-4847-884B-F19EC5C3590A Q36368434-91D2579A-07E6-4167-8B45-B76DAEA347B5 Q36470642-12E62200-A84F-45F6-A996-4BB8CFB73140 Q36575306-98AD3CB6-0C0B-44EA-9485-68CCFF521C2F Q36598477-2431EB6D-D504-4E04-A653-AAE7486920E3 Q36690859-A94C0681-F184-43C7-A9AC-573496B644D1 Q36711000-A3DEC3C4-6941-499B-BF94-4BA856D4DECB Q36944484-52590739-FEC2-42D8-A4E6-DAB5700CEB55 Q37257144-10BCB9DA-96DF-4313-9AA9-BADFA15F7A62 Q37396098-DD429568-601D-4DCE-8584-F5FA405CF34F Q37396113-3663A878-938C-468B-96D7-CB03FB809FA3 Q37401116-6275B206-3E3F-4E62-B5CC-89A8D59281F6 Q37404262-9B24BDFC-4834-4A55-B043-8E1091BCFCCD Q37676046-A5CAE0A5-8C97-42D3-98CF-9A704867BA1A Q37832678-16BEE76D-FFCA-4E07-BFAD-4C0D3464CF42 Q37860197-363D2856-F062-48CB-A87F-C6DAEC02B64B Q38226005-660B1036-523E-4412-82B7-B4973FCB1665 Q38260351-8BE929E0-136D-404F-8D33-AA24FB94F6C2 Q38415235-18C35C8A-ADE1-419C-9161-1F98A67B5C37 Q38444555-3BF288FF-A24B-4DD9-A112-81110D2889D7 Q38556840-E90B0071-0727-4BBA-8C5A-992800629EE1 Q38616606-7C93B3C2-5D98-4675-B2DA-7872EE4C200D Q38630043-43CF8377-6737-468B-B9C4-E2F63FA5837C Q38706078-6B575501-498B-4E45-841B-DC8123D9CF7C

P2860

Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells.

http://www.wikidata.org/entity/Q51003792

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Proteomic analysis and quantif ...... and foreign body giant cells.

@en

Proteomic analysis and quantif ...... and foreign body giant cells.

@nl

type

label

Proteomic analysis and quantif ...... and foreign body giant cells.

@en

Proteomic analysis and quantif ...... and foreign body giant cells.

@nl

prefLabel

Proteomic analysis and quantif ...... and foreign body giant cells.

@en

Proteomic analysis and quantif ...... and foreign body giant cells.

@nl

P1433

Q51003792-783B623F-D204-4F33-BB08-847046BA077C

P1476

Q51003792-CDF4B415-DE63-418E-A98F-81AB42600787

P2093

Q51003792-3B6F8CB1-FF0D-48C4-8779-7D7F84CF897B

Q51003792-564223E4-F20F-4311-B09B-2489D97415A6

Q51003792-7E7A69E7-3670-44BB-A13D-174CBD672ECD

Q51003792-7FF0C51C-973F-4E52-BBD7-6D9C7F99B6B7

Q51003792-81C836A0-C661-4C8E-9E68-94CE13A51CF7

Q51003792-D93A2203-135C-41AE-912A-6150D7FE7C38

Q51003792-E4AB1EB5-5097-4E24-A622-FFDC098FD8F2

P2860

Q51003792-D51ACCAE-38A1-471B-87B2-7D2782539148

P304

Q51003792-FA5D3753-685F-40A7-A32F-DD7A036F8F06

P31

Q51003792-6C88CD8B-2F28-4FB7-B71D-2DE5C85F67D1

P356

Q51003792-8F8A62E9-175C-4633-A76C-D7C29F86A88B

P433

Q51003792-7829AA9E-9455-467A-BD0F-7519AE79E438

P478

Q51003792-9EA68907-52FB-4898-84D4-04DD2C61520A

P577

Q51003792-57BC591F-1362-4016-BB97-E156942A2627

P698

Q51003792-E8945FCD-9D7C-46FE-9B50-A1D8450F98E5

P356

P1433

Journal of Biomedical Materials Research Part A

P1476

Proteomic analysis and quantif ...... and foreign body giant cells.

@en

P2093

David T Chang

http://www.w3.org/2001/XMLSchema#string

Erica Colton

http://www.w3.org/2001/XMLSchema#string

Howard Meyerson

http://www.w3.org/2001/XMLSchema#string

Il Keun Kwon

http://www.w3.org/2001/XMLSchema#string

Jacqueline A Jones

http://www.w3.org/2001/XMLSchema#string

James M Anderson

http://www.w3.org/2001/XMLSchema#string

Takehisa Matsuda

http://www.w3.org/2001/XMLSchema#string

P2860

CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages.

P304

585-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.A.31221

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17503526

http://www.w3.org/2001/XMLSchema#string